|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
D
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
unusual tiredness |
|
vertigo |
|
vomiting |
|
weight gain |
|
Alopecia |
|
Dyspnea |
|
Bone fracture |
|
breast pain |
|
chest pain |
|
edema, peripheral |
|
hypertension |
|
mental depression |
|
pleural effusion |
|
viral infection |
|
Myocardial infarction |
|
myocardial ischemia |
|
pulmonary embolism |
|
thromboembolism |
|
vaginal bleeding |
|
Arthralgia |
|
back pain |
|
bone pain |
|
hot flashes |
|
myalgia |
|
nausea |
|
Anorexia |
|
anxiety |
|
asthenia |
|
constipation |
|
cough |
|
diarrhea |
|
dizziness |
|
headache |
|
hypercalcemia |
|
hypercholesterolemia (high cholesterol) |
|
increased sweating |
|
insomnia |
|
skin rash or itching |
|
sleepiness |
|
stomach pain or upset |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Hepatic function impairment |
|
Renal function impairment |
|
|
ADULT DOSE:
|
|
Carcinoma, breast-
Oral, 2.5 mg once a day. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Carcinoma, breast-
Oral, 2.5 mg once a day. |
|
|
|
|
|